National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "1 Introduction and Background." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
42
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety

Prevention Magazine. 2001. Consumer Use of Dietary Supplements. Emmaus, PA: Rodale. Pp. 1–79.


Radimer KL, Subar AF, Thompson FE. 2000. Nonvitamin, nonmineral dietary supplements: Issues and findings from NHANES III. J Am Diet Assoc 100:447–454.

Ramos L. 2000. SAMe as a supplement: Can it really help treat depression and arthritis? J Am Diet Assoc 100:414.


Sarubin A. 2000. The Health Professional’s Guide to Popular Dietary Supplements. Chicago, IL: American Dietetic Association.

Scientific Committee on Food. 1999. Opinion on Stevioside as a Sweetener. European Commission. CS/ADD/EDUL/167 final. Brussels: European Commission. Available at http://europa.eu.int/comm/food/fs/sc/scf/out34_en.pdf. Accessed March 25, 2004.

Sinclair U. 1906. The Jungle. New York: Doubleday.

Slesinski MJ, Subar AF, Kahle LL. 1995. Trends in use of vitamin and mineral supplements in the United States: The 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc 95:921–923.

Subar AF, Block G. 1990. Use of vitamin and mineral supplements: Demographics and amounts of nutrients consumed. The 1987 Health Interview Survey. Am J Epidemiol 132:1091–1101.


Vital Nutrients. 2001. Vital Nutrients Recalls Joint Ease and Verified Quality Brand Joint Comfort Complex Because of Adverse Health Risk Associated with Aristolochic Acid. Online. May 21. News release. Available at http://www.fda.gov/oc/po/firmrecalls/vital5_01.html. Accessed March 8, 2002.


Wasuntarawat C, Temcharoen P, Toskulkao C, Mungkornkarn P, Suttajit M, Glinsukon T. 1998. Developmental toxicity of steviol, a metabolite of stevioside, in the hamster. Drug Chem Toxicol 21:207–222.

Wax PM. 1995. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med 122:456–461.

Wetli CV, Davis JH. 1978. Fatal hyperkalemia from accidental overdose of potassium chloride. J Am Med Assoc 240:1339.


Yamada A, Ohgaki S, Noda T, Shimizu M. 1985. Chronic toxicity study of dietary stevia extracts in F344 rats. J Food Hyg Soc Japan 26:169–183.

Young AL, Bass IS. 1995. The Dietary Supplement Health and Education Act. Food Drug Law J 50:285–292.

Page
42
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)